Biogen Idec

www.biogenidec.ch

Landis and Gyr-Strasse 3
Zug
CH-6300
Switzerland

+41 41 39 21700

Activities

Manufacturing | Pharmaceutical

Related Companies

Related Content

Latest EU drug approvals span range of health issues
Latest EU drug approvals span range of health issues
Alzheimer’s treatment market value to exceed US$13bn by 2023
Alzheimer’s treatment market value to exceed US$13bn by 2023
Alzheimer’s Research UK and J&J to back new US$100m Dementia Discovery Fund
Alzheimer’s Research UK and J&J to back new US$100m Dementia Discovery Fund
Biogen Idec forms pact with Columbia University to conduct genetics discovery research
Biogen Idec forms pact with Columbia University to conduct genetics discovery research
Biogen Idec to buy Convergence Pharmaceuticals
Biogen Idec to buy Convergence Pharmaceuticals
NCEs target cancer
NCEs target cancer
Eisai and Biogen Idec enter Alzheimer\'s disease collaboration
Eisai and Biogen Idec enter Alzheimer\'s disease collaboration
Biotech facilities take the honours at FOYA awards
Biotech facilities take the honours at FOYA awards
Therapeutic nucleotides: targeting genes
Therapeutic nucleotides: targeting genes
Judges announce 2013 Facility of the Year Awards winners
Judges announce 2013 Facility of the Year Awards winners
Biogen Idec forms ALS research consortium
Biogen Idec forms ALS research consortium
A lucrative niche in orphan diseases?
A lucrative niche in orphan diseases?
Heart failure – lixivaptan
Heart failure – lixivaptan
The role of partnership in building value
The role of partnership in building value
Biogen Idec to acquire Stromedix
Biogen Idec to acquire Stromedix